Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.31 |
| ▸ | LSS | P48449 | 1/20 | 0.31 |
| ▸ | GSR | P00390 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25139315 | 0.85 | NLRP3 (0.33) | NLRP3ROCK2CYP2D6CYP2C19LSS | |
| SCHEMBL20698683 | 0.83 | NLRP3 (0.39) | NLRP3ROCK2CYP2D6CYP2C19OPRK1 | |
| SCHEMBL22014445 | 0.83 | NLRP3 (0.39) | NLRP3ROCK2CYP2D6CYP2C19OPRK1 | |
| SCHEMBL22014582 | 0.82 | NLRP3 (0.34) | NLRP3ROCK2LSSGSR | |
| SCHEMBL20698684 | 0.81 | NLRP3 (0.33) | NLRP3ROCK2LSSGSR | |
| SCHEMBL25067186 | 0.81 | NLRP3 (0.39) | NLRP3OPRK1LSS | |
| SCHEMBL23692211 | 0.79 | ROCK2 (0.35) | NLRP3ROCK2CYP2D6LSS | |
| SCHEMBL20698800 | 0.78 | NLRP3 (0.38) | NLRP3ROCK2LSS | |
| SCHEMBL22014583 | 0.77 | NLRP3 (0.42) | NLRP3NSD2ROCK2OPRK1HSP90AA1 | |
| SCHEMBL20698687 | 0.77 | NLRP3 (0.42) | NLRP3NSD2ROCK2OPRK1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102574-A1 | THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |